SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:lup.lub.lu.se:38968d6f-a548-4909-9fbb-a14640b869de"
 

Search: onr:"swepub:oai:lup.lub.lu.se:38968d6f-a548-4909-9fbb-a14640b869de" > Effect of mobilizat...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Effect of mobilization of bone marrow stem cells by granulocyte colony stimulating factor on clinical symptoms, left ventricular perfusion and function in patients with severe chronic ischemic heart disease

Wang, YZ (author)
Tägil, Kristina (author)
Lund University,Lunds universitet,Nuklearmedicin, Malmö,Forskargrupper vid Lunds universitet,Nuclear medicine, Malmö,Lund University Research Groups
Ripa, RS (author)
show more...
Nilsson, JC (author)
Carstensen, S (author)
Jorgensen, E (author)
Sondergaard, L (author)
Hesse, B (author)
Johnsen, HE (author)
Kastrup, J (author)
show less...
 (creator_code:org_t)
Elsevier BV, 2005
2005
English.
In: International Journal of Cardiology. - : Elsevier BV. - 0167-5273. ; 100:3, s. 477-483
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Objectives: A phase I safety and efficacy study with granulocyte colony stimulating factor (G-CSF) mobilization of bone marrow stem cells to induce vasculogenesis in patients with severe ischemic heart disease (IHD) was conducted. Design, patients and results: 29 patients with IHD participated in the study. Thirteen patients were treated with G-CSF for 6 days and 16 patients served as controls. G-CSF treatment was without any serious adverse events. Four patients were "poor mobilizers" with a maximal increase in CD34+ cells to 5,000 +/- 700/mL blood (mean +/- S.D.) compared to 28,900 +/- 5,100/mL blood in "mobilizers". At the follow-up, G-CSF treated had improved in CCS classification, NTG consumption and angina attacks, but the controls only in CCS classification. No difference was seen between the two groups. The decline in NTG consumption tended to be significant in "mobilizers" compared to controls. Myocardial perfusion was unchanged at adenosine stress single photon emission computerized tomography (SPECT) or magnetic resonance images (MRI). Left ventricular ejection fraction decreased from 57% to 52% (p < 0.01, MRI) and from 48% to 44% (p=0.07, SPECT) in G-CSF treated, but was unchanged measured with echocardiography. Conclusions: Treatment by G-CSF improved symptoms but not signs of myocardial ischemia in patients with severe IHD. The effects seemed related to mobilization of stem cells. An adverse effect on ejection fraction could not be excluded. (c) 2005 Published by Elsevier Ireland Ltd.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Keyword

G-CSF
ejection fraction
left ventricular
ischemic heart disease
stem cells
vasculogenesis

Publication and Content Type

art (subject category)
ref (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view